From a nationwide telehealth rollout to lobbying Congress for home healthcare reimbursement, we detail Amazon’s most significant healthcare plays in 2021.
We look back on our top digital health predictions for 2020—and we dive into why the ones we got wrong didn’t hold water.
Consumers are turning to mobile health apps to treat their health: We highlight the key points from our recently released Mobile Health Apps for Disease Management report, detailing what’s driving the rise of mobile health apps and where it’s headed.
Our outlook on the consumerization of healthcare in 2022: The pandemic accelerated digital health adoption and the transformation of the US health system. Now, digital health vendors must prove their tools aren’t just convenient—but that they’re as high-quality as traditional, in-person methods.
Nearly 100% of large hospitals in the US reported a nursing shortage a month before the omicron variant arrived.
Digital healthcare payments startups to watch in 2022: We highlight the buzziest startups disrupting the healthcare payments space over the last year—from major funding hauls to game-changing partnerships—and detail why they’re worth keeping an eye on in 2022.
What the phasing out of 3G will mean for telehealth in rural regions: As digital health transformation takes US healthcare by storm, rural areas are getting left behind—here’s how the advent of 5G could change that.
A look back at Microsoft’s bustling year in healthcare: From a multibillion dollar acquisition to new tech launches, we detail Microsoft’s 5 most significant healthcare plays in 2021.
We look back on our top digital health predictions for 2020—and delve into which held up in the year of multibillion-dollar M&As.
What Oracle’s rumored Cerner acquisition would mean for the EHR market: The reported $30 billion acquisition would put Oracle back on the map in healthcare cloud, and shake up the market dynamics between Epic and Cerner. More on this below.
Its $13 billion Change Healthcare M&A deal came under fire and is now being delayed ‘til at least April 2022. We detail why regulators are concerned.
As the COVID-19 pandemic wears on, US healthcare providers are incorporating telehealth into their practice, particularly when treating new concerns.